Position in ANIP
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$22,523,196
+$11,212,360 QoQ
Shares Held
272,085
+85.0% QoQ
Ownership
1.18%
of shares outstanding
% of Portfolio
3.65%
of 13F equity value
Holder Rank
#21
of 303 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANIP Over Time
Shares Held
Position Value (USD)
Derivatives in ANIP
reported options exposure · as of Mar 31, 2026CallValue
$11,535,000
CallShares
150,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Ikarian Capital, LLC holds $50,945,474 across 10 Drug Manufacturers - Specialty & Generic names. ANIP ranks #1 (44.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ANIP |
Ani Pharmaceuticals Inc
This page
|
272,085 | $22,523,196 | |
| 2 | HIMS |
Hims & Hers Health, Inc.
|
188,381 | $6,531,169 | |
| 3 | HROW |
Harrow, Inc.
|
135,775 | $5,766,364 | |
| 4 | BIOA |
BioAge Labs, Inc.
|
200,000 | $4,902,000 | |
| 5 | CRDL |
Cardiol Therapeutics Inc.
|
3,325,000 | $3,524,500 | |
| 6 | CPIX |
Cumberland Pharmaceuticals Inc
|
503,153 | $3,260,431 | |
| 7 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
117,500 | $2,110,300 | |
| 8 | DERM |
Journey Medical Corp
|
251,436 | $1,780,166 |
All Filings in ANIP
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $22,523,196 | 272,085 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $11,310,836 | 147,085 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $11,535,000 | 150,000 | Call | Sole | 2026-05-15 | |
| 2025-12-31 | $6,536,232 | 82,800 | Call | Sole | 2026-02-18 | |
| No filing history on record for this holder in this stock. | ||||||